Literature DB >> 26061168

Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in an Asian population: Secular trends of a population-based cancer registry from 1998 to 2012.

Raymond Boon Tar Lim1,2, En Yun Loy1, Gek Hsiang Lim1, Huili Zheng1, Khuan Yew Chow1, Soon Thye Lim3,4.   

Abstract

Descriptive epidemiology on incidence and survival by lymphoid neoplasm (LN) subtypes using the 2008 World Health Organisation (WHO) classification remained limited in Asia. The aim of this study was to evaluate whether gender and ethnic differences in incidence and survival of LN subtypes existed using the Singapore Cancer Registry (SCR) from 1998 to 2012. We derived age standardised incidence rates (ASIRs) by the direct standardisation method and 5-year relative survival (RSR) by the Ederer II method and period approach. Five-year observed survival (OS) was obtained for each ethnicity. Malays had the highest ASIR of total LNs among the three ethnicities for each time period. The largest increase in 5-year RSR subtypes was follicular lymphoma from 43.8% in 1998-2002 to 82.3% in 2008-2012; followed by chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL) from 48.1% in 1998-2002 to 77.9% in 2008-2012. Although males had higher incidence than females in each time period, females had greater 5-year RSR for follicular lymphoma (89.8% in 2008-2012 for females vs. 76.6% in 2008-2012 for males) and CLL/SLL (78.7% in 2008-2012 for females vs. 76.7% in 2008-2012 for males). All three ethnicities experienced an overall increase in 5-year OS for mature B-cell lymphoma, with Indians experiencing the greatest increase (37.1% in 1998-2002 to 61.1% in 2008-2012), followed by Malays (30.8% in 1998-2002 to 48.7% in 2008-2012) and then Chinese (36.4% in 1998-2002 to 51.3% in 2008-2012). Our study demonstrated that improved mature B-cell lymphoma survival was not only observed in the West, but also in Singapore.
© 2015 UICC.

Entities:  

Keywords:  Singapore; cancer registry; incidence; lymphoid neoplasm; lymphoma; survival

Mesh:

Year:  2015        PMID: 26061168     DOI: 10.1002/ijc.29635

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Cancer survival in Qidong between 1972 and 2011: A population-based analysis.

Authors:  Jian-Guo Chen; Jian Zhu; Yong-Hui Zhang; Yi-Xin Zhang; Deng-Fu Yao; Yong-Sheng Chen; Jian-Hua Lu; Lu-Lu Ding; Hai-Zhen Chen; Chao-Yong Zhu; Li-Ping Yang; Yuan-Rong Zhu; Fu-Lin Qiang
Journal:  Mol Clin Oncol       Date:  2017-05-03

Review 2.  Epidemiology of Follicular Lymphoma.

Authors:  James R Cerhan
Journal:  Hematol Oncol Clin North Am       Date:  2020-05-05       Impact factor: 3.722

3.  Quality of life amongst lymphoma survivors in a developing country.

Authors:  Diana L C Ng; Y C Leong; Gin Gin Gan
Journal:  Support Care Cancer       Date:  2016-07-26       Impact factor: 3.603

4.  Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States.

Authors:  Chadi Nabhan; Xiaolei Zhou; Bann-Mo Day; Keith Dawson; Andrew D Zelenetz; Jonathan W Friedberg; James R Cerhan; Brian K Link; Christopher R Flowers
Journal:  Am J Hematol       Date:  2016-05-24       Impact factor: 10.047

5.  Epidemiology of Marginal Zone Lymphoma.

Authors:  James R Cerhan; Thomas M Habermann
Journal:  Ann Lymphoma       Date:  2021-03-30

6.  Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib.

Authors:  Jörg Mahlich; Shinichiro Okamoto; Akiko Tsubota
Journal:  Pharmacoecon Open       Date:  2017-09

7.  Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.

Authors:  Xibiao Ye; Salaheddin Mahmud; Pamela Skrabek; Lisa Lix; James B Johnston
Journal:  BMJ Open       Date:  2017-07-17       Impact factor: 2.692

Review 8.  Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group.

Authors:  Dok Hyun Yoon; Junning Cao; Tsai-Yun Chen; Koji Izutsu; Seok Jin Kim; Yok Lam Kwong; Tong Yu Lin; Lim Soon Thye; Bing Xu; Deok Hwan Yang; Won Seog Kim
Journal:  J Hematol Oncol       Date:  2020-03-17       Impact factor: 17.388

9.  Incidence of non-Hodgkin's lymphoma among adults in Sardinia, Italy.

Authors:  Giorgio Broccia; Jonathan Carter; Cansu Ozsin-Ozler; Federico Meloni; Sara De Matteis; Pierluigi Cocco
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.